Another recent study demonstrated immune dysregulation in both iPSC-SCPs and iPSC-derived Schwann cells (CXCL1 and MCP-1 overexpression) from CMT1A patient lines across different stem cell lines and differentiation protocols50. The gene discussed is CCL2; the disease is Charcot-Marie-Tooth disease type 1A.